Showing results (41-50 of 76) with videos related to
Sort By:
Pageof 8
World Journal of Urology|March 29, 2021
A qualitative framework of non-selection factors for cytoreductive nephrectomyAndrew W Silagy, Kyrollis Attalla, Renzo G Dinatale, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 5, 2025
A Phase I Dose-Escalation Study of the HIF-2 Alpha Inhibitor DFF332 in Patients with Advanced Clear-Cell Renal Cell CarcinomaSumanta K Pal, Alice Bernard-Tessier, Peter Grell, et al.Urologic Oncology|September 12, 2025
Long-term oncologic outcomes of metastatic clear-cell renal cell carcinoma after local therapy aloneDaniel Barbakoff, Mark T Dawidek, Andrea Knezevic, et al.Urologic Oncology|September 6, 2025
Radiomic biomarkers associated with immune checkpoint blockade response for advanced renal cell carcinomaStephen W Reese, Daniel Barbakoff, Burcin Agridag Ucpinar, et al.British Journal of Haematology|May 16, 2021
Combined haploidentical and cord blood transplantation for refractory severe aplastic anaemia and hypoplastic myelodysplastic syndromeRichard W Childs, Xin Tian, Phuong Vo, et al.Journal for Immunotherapy of Cancer|June 24, 2020
DNA damage repair pathway alterations in metastatic clear cell renal cell carcinoma and implications on systemic therapyYasser Ged, Joshua L Chaim, Renzo G DiNatale, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 14, 2026
Allogeneic CD70-Targeted Chimeric Antigen Receptor T-Cell Therapy for Advanced Renal Cell Carcinoma: Results From the Phase I TRAVERSE TrialSamer A Srour, Jad Chahoud, Alexandra Drakaki, et al.European Journal of Cancer (Oxford, England : 1990)|May 11, 2019
Outcomes of patients with metastatic clear-cell renal cell carcinoma treated with second-line VEGFR-TKI after first-line immune checkpoint inhibitorsA Y Shah, R R Kotecha, E A Lemke, et al.Transplantation and Cellular Therapy|February 24, 2025
Infections in Patients with Solid Tumors Undergoing Adoptive Cellular TherapyViswatej Avutu, Jumanah N Algazaq, Kenneth Seier, et al.European Urology|May 23, 2024
Cabozantinib Plus Nivolumab in Patients with Non-Clear Cell Renal Cell Carcinoma: Updated Results from a Phase 2 TrialKelly N Fitzgerald, Chung-Han Lee, Martin H Voss, et al.Pageof 8